What doesn't kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands-Reference-Cited by-同舟云学术

What doesn't kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands

Published:2019-06 Issue: Volume:198 Page:90-108
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Elmansi Ahmed M.,Awad Mohamed E.,Eisa Nada H.,Kondrikov Dmitry,Hussein Khaled A.,Aguilar-Pérez Alexandra,Herberg Samuel,Periyasamy-Thandavan Sudharsan,Fulzele Sadanand,Hamrick Mark W.,McGee-Lawrence Meghan E.,Isales Carlos M.,Volkman Brian F.,Hill William D.

Funder

VA Merit Award

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference192 articles.

1. Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene;Abbott;Immunogenetics,1994

2. Proteolytic processed form of CXCL12 abolishes migration and induces apoptosis in neural stem cells in vitro;Adelita;Stem Cell Research,2017

3. Human distribution and release of a putative new gut hormone, peptide YY;Adrian;Gastroenterology,1985

4. Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration;Ambrosi;Cell Stem Cell,2017

5. Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors;Anderluh;Pharmacology & Therapeutics,2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preventing CXCL12 elevation helps to reduce acute exacerbation of COPD in individuals co-existing type-2 diabetes: A bioinformatics and clinical pharmacology study;International Immunopharmacology;2024-05

2. Decreased circulating dipeptidyl peptidase-4 activity after short-term intensive insulin therapy predicts clinical outcomes in patients with newly diagnosed type 2 diabetes;Frontiers in Endocrinology;2024-02-27

3. Enhanced ileum function in weaned piglets via Laminaria digitata and alginate lyase dietary inclusion: A combined proteomics and metabolomics analysis;Journal of Proteomics;2023-10

4. Dipeptidyl Peptidase 4 Inhibitor‒Associated Bullous Pemphigoid Is Characterized by an Altered Expression of Cytokines in the Skin;Journal of Investigative Dermatology;2023-01

5. Nonenzymatic function of DPP4 promotes diabetes-associated cognitive dysfunction through IGF-2R/PKA/SP1/ERp29/IP3R2 pathway-mediated impairment of Treg function and M1 microglia polarization;Metabolism;2023-01